HornScout
Sign inAccessRequest access

HornScout — Market Intelligence Platform

AboutMethodologyPrivacyTermsInvestment disclaimerContact

Company profile

DFTX

Definium Therapeutics, Inc.
NASDAQHealthcare

End-of-day prices provided by Twelve Data · One close per session. Not real time and not a quote.

Regulatory history
The company's SEC filings, in plain language.
  • 2026-05-07 share offering or dilution eventrecentOpen filing ↗
    “…in or acquire additional businesses or compounds that the Company believe are complementary to its own . 8. WARRANTS 2022 USD…”
    +1 more passage from the same document
    • “…Accrued other research and development costs 824 1,238 Professional services 2,827 895 Other accruals 604 510 Total $ 24,514 $ 20,446…”
  • 2026-05-07 capital return (buybacks/dividends)recentOpen filing ↗
    “…preferences that adversely affect the rights of our common shareholders. Debt financing and preferred equity financing, if available,…”

Recorded SEC filings in plain language — not advice or a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

Stress1Structure15Governance11
  • Jun 24, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 12, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 29, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 31, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 16, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 27, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 21, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jan 13, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure5 material agreements entered2023 – 2024show all 5hide
    • Oct 17, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Aug 12, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jun 28, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 11, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Aug 14, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 18, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 29, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 11, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

5 older filings not shown

Notable in the record

Stress disclosed to the SEC that the timeline above does not reach, by age. Not a timeline: these are the individual facts, with no claim that nothing else sat between them.

  • Jun 2, 22StressNotice of failing exchange listing standards+1 more in the same filing8-K 3.01 ↗

The full record holds 1 stress filing.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Passive holders

Filed on Schedule 13G: large stakes held without an intention to control — mostly index and institutional funds.

  • BlackRock, Inc.8.3%Dec 31, 24SCHEDULE 13G/A ↗
  • DRIEHAUS CAPITAL MANAGEMENT LLC5.4%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Avoro Capital Advisors LLC5.1%Dec 31, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Deep Track Capital, LP3.0%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Commodore Capital LP1.8%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

455 filings on record, the oldest from Mar 30, 21.

  • 2 SCHEDULE 13G/A filingsshow all 2hide
    • Aug 14, 26SCHEDULE 13G/A ↗amendment
    • Aug 14, 26SCHEDULE 13G/A ↗amendment
  • 5 Form 4 filingsshow all 5hide
    • Aug 12, 26Form 4 ↗
    • Aug 12, 26Form 4 ↗
    • Aug 12, 26Form 4 ↗
    • Aug 12, 26Form 4 ↗
    • Aug 12, 26Form 4 ↗
  • Aug 12, 268-K ↗
  • Aug 6, 2610-Q ↗
  • Aug 6, 268-K ↗
  • 5 Form 4 filingsshow all 5hide
    • Jun 26, 26Form 4 ↗
    • Jun 26, 26Form 4 ↗
    • Jun 26, 26Form 4 ↗
    • Jun 26, 26Form 4 ↗
    • Jun 26, 26Form 4 ↗
  • 5 Form 144 filingsshow all 5hide
    • Jun 25, 26Form 144 ↗
    • Jun 25, 26Form 144 ↗
    • Jun 25, 26Form 144 ↗
    • Jun 25, 26Form 144 ↗
    • Jun 25, 26Form 144 ↗
  • Jun 24, 268-K ↗
  • Jun 24, 26424B5 ↗
  • 3 Form 4 filingsshow all 3hide
    • Jun 22, 26Form 4 ↗
    • Jun 22, 26Form 4 ↗
    • Jun 22, 26Form 4 ↗

Listing the 25 most recent filings of the 455 on record.

Sale intention announced

On Jun 25, MARK SULLIVAN filed notice of intent to sell up to $548K. That is about 0.01% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $586K on Jun 25, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+4 more recent notices · 4 with a later sale✉ Email alerts for these are coming soon.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 25, 26Sell$129KMatthew T. WileyChief Commercial Officer↗
  • Jun 25, 26Sell$1.3MRobert BarrowChief Executive Officer↗
  • Jun 25, 26Sell$136KBrandi RobertsChief Financial Officer↗
  • Jun 25, 26Sell$452KDaniel KarlinChief Medical Officer↗
  • Jun 25, 26Sell$586KMark SullivanChief Legal Officer↗
  • Mar 25, 26Sell$451KRobert BarrowChief Executive Officer↗
  • Mar 25, 26Sell$198KMark SullivanChief Legal Officer↗
  • Mar 25, 26Sell$148KDaniel KarlinChief Medical Officer↗
  • Dec 26, 25Sell$148KMark SullivanChief Legal Officer↗
  • Dec 26, 25Sell$339KRobert BarrowChief Executive Officer↗
  • Dec 26, 25Sell$74KDaniel KarlinChief Medical Officer↗
  • Sep 25, 25Sell$75KDaniel KarlinChief Medical Officer↗

There are 7 more transactions in this stretch.

Stock compensation, tax and giftsshow the 21 mechanical oneshide

Tax, stock compensation and option exercises. These are not decisions to buy or sell, so they sit apart and never enter the totals above. The amount can be huge without meaning conviction.

  • Aug 12, 26Compensationamount n/aBrandi RobertsChief Financial Officer↗
  • Aug 12, 26Compensationamount n/aMatthew T. WileyChief Commercial Officer↗
  • Aug 12, 26Compensationamount n/aMark SullivanChief Legal Officer↗
  • Aug 12, 26Compensationamount n/aDaniel KarlinChief Medical Officer↗
  • Aug 12, 26Compensationamount n/aRobert BarrowChief Executive Officer↗
  • Jun 22, 26Compensationamount n/aDaniel KarlinChief Medical Officer↗
  • Jun 22, 26Compensationamount n/aMark SullivanChief Legal Officer↗
  • Jun 22, 26Compensationamount n/aBrandi RobertsChief Financial Officer↗
  • Jun 22, 26Compensationamount n/aMatthew T. WileyChief Commercial Officer↗
  • Jun 22, 26Compensationamount n/aRobert BarrowChief Executive Officer↗
  • Jun 11, 26Compensationamount n/aSuzanne Louise Bruhn↗
  • Jun 11, 26Compensationamount n/aRoger Adsett↗
  • Jun 11, 26Compensationamount n/aAndreas Krebs↗
  • Jun 11, 26Compensationamount n/aCarol A Vallone↗
  • Jun 11, 26Compensationamount n/aDAVID W GRYSKA↗
  • Jun 11, 26Compensationamount n/aROGER CRYSTAL↗
  • Feb 3, 26Compensationamount n/aRobert BarrowChief Executive Officer↗
  • Feb 3, 26Compensationamount n/aDaniel KarlinChief Medical Officer↗
  • Feb 3, 26Compensationamount n/aMark SullivanChief Legal Officer↗
  • Feb 3, 26Compensationamount n/aBrandi RobertsChief Financial Officer↗
  • Feb 3, 26Compensationamount n/aMatthew T. WileyChief Commercial Officer↗

The full record holds 95 transactions and goes back to Mar 1, 23.

← All companiesCompanies listed on NASDAQHealthcare companies

Beta

The rest of the read needs an account.

Scores, historical analogues, watchlist and Radar work over the same companies you can already browse here.

Request accessSign in

Invite-only beta. Payments are not active yet.